Our results, which was confirmed by deconvoluting the DR ligandome of the clinical samples from RA patients, indicate that DRB4 molecules, due to their limited repertoire, do not contribute to the diversity and extent of the haplotype total peptidome at the same level as DRB3 and DRB5. The gene discussed is HLA-DRB5; the disease is rheumatoid arthritis.